LATEST NEWS
  •  
    New market-access concerns drive an expansion in this combination of financial and medical concerns
    While it is hardly a new line of work, HEOR (health economics and outcomes research) is experiencing a period of rapid growth, driven by the increased need to provide payers with meaningful data on drugs' effects on patients. So says a recently published report from ISR Reports, whose authors say that "Pharma needs to sell the story of a strong value proposition for its products and HEOR is the way to do it." The ISR study, Benchmarking the pharma industry's HEOR functions, surveyed about 20 top 50 pharma companies, collecting commentary on best practices, costs and staffing
  •  
    A potential unintended consequence of the Physicians Sunshine Act: Some job-candidate interviews will become a publicly accessible record
    It's still early innings in the implementation of the Physicians Sunshine Act, a part of the Affordable Care Act that requires pharma and med device companies to report financial arrangements or other "transfers of value" to licensed physicians and other healthcare providers. Now, there are signs that it will have broader impact: Money spent in the process of recruiting job candidates could become reportable events--and that report could become a publicly accessible record
  •  
    Innovation award goes to Mem-O-Ring, a pill-bottle attachment
    The annual competition, conducted by the Healthcare Compliance Packaging Council (HCPC; Reston, VA), is intended to highlight the role compliance (unit-dose) packaging plays in helping patients stay on therapy, helping healthcare providers improve outcomes, and helping the pharma industry better its value to all parts of healthcare. This year's award, announced at HCPC's annual RxAdherence conference (April 8) is Brisdelle (paroxetine), introduced last November by Noven Therapeutics (Miami) as a treatment for vasomotor symptoms associated with menopause. The competition is based
  •  
    Mexico, Brazil and Chile will see new or expanded healthcare logistics capability
  •  
    Fast-tracked product is acclaimed by FDA as well as its developer, Kaleo
    On a not-serious level, one can ask, "Why didn't I think of that?" But on another, much more serious level, there's news from FDA and Kaleo (Richmond, VA) that could lead--very quickly--to saving lives and providing some good news in the generally grim topic of opioid abuse. On Apr. 3, FDA announced approval of a new drug-device combination, Kaleo's Evzio auto-injector, to provide treatment of patients in an opioid-overdose emergency. Somewhat like an epinephrine autoinjector (a product that Kaleo also developed--marketed by Sanofi-Aventis--as the Auvi-Q autoinjector), a family member, emergency medical technician
  •  
    Pharmaceutical Commerce's latest report finds continued growth in these specialized logistics services
    The 5th edition of the Biopharma Cold Chain Sourcebook analyzes economic, regulatory and technological trends in a vital part of today's industry: the shipment of temperature-controlled products. The just-published report calculates that current (2014) expenditures for commercial shipments will be $8.36 billion, rising to $10.28 billion in 2018. By comparison, last year's Sourcebook estimated the 2013 cold-chain business to be $7.5 billion, rising
  •  
    Pharma companies assess their ongoing reporting capabilities
    The midnight oil is burning at many pharma companies as they make their final preparations for submitting aggregate-spending data to CMS by March 31, a requirement under the Physicians Sunshine Act. Recent reporting indicates that the Sunshine Act has already had an impact on physicians' acceptance of speaker fees; now, Cegedim Relationship Management (Bedminster, NJ) is reporting that 64% of surveyed physicians say that the law will have an effect on their interactions
  •  
    Company also announces a 10-year agreement with Salesforce.com
    Veeva (Pleasanton, CA) started as a conventional (if cloud-based) salesforce-automation (SFA) tool, but in the past couple years has expanded its capabilities to include storage and sharing of promotional documents, laboratory filings, master-data management and regulated email. Now it is adding multichannel communications--with an emphasis on mobile--to its slate of offerings. The new service, called Engage, enables pharma sales reps to communicate with physicians via interactive voice or email. In effect, Veeva
Pharmaceutical Commerce
Digital Edition
Nov/Dec Digital Edition
Read the March/April 2014 Issue now - It's Free!
COLD CHAIN FOCUS
Enhanced reuse could be possible with ProEnvision system
 
INDUSTRY EVENTS
 
 
 
 
WHAT THEY'RE SAYING
Pharmaceutical Commerce sat down with Bill Hook, VP, Global Strategy – Healthcare Logistics, who is now taking on a role as senior advisor to the business unit, and John Menna, the new VP, Global Strategy – Healthcare Logistics, incoming leader for the group, to discuss the place of logistics in today’s life sciences industry. Here’s what they had to say.
 
 
FEATURES
Cold chain packagers balance cost, performance and compliance approaches  continued >
 
Competitive forces sharpen as manufacturers look for the right channel partners  continued >
 
How new social health analytics tools are supercharging pharma's quest for patient insights   continued >
 
Drug Quality and Security Act's timetables for FDA, manufacturers, wholesalers, dispensers and 3PLs  continued >
 
The trend toward self-administered drugs creates a pressing need for better patient-education resources  continued >
 
 
MOST POPULAR STORIES
 
 
SPECIAL FOCUS REPORT
2014 HUB Services Report
 
Competitive forces sharpen as manufacturers look for the right channel partners
 
 
 
 
   
  |     |     |     |     |     |  
©2014 Pharmaceutical Commerce. All Rights Reserved.  |  Website managed and designed by Offenberger & White.